** = Publikationen gelistet in SCI/SSCI/Pubmed
** Spiliopoulos, S; Hergesell, V; Wasler, A; Dapunt, O
Current state of total artificial heart therapy and introduction of the most important total artificial heart systems.
Biomed Tech (Berl). 2019; 64(3):247-250
Doi: 10.1515/bmt-2017-0095
Web of Science
PubMed
FullText
FullText_MUG
** Aliabadi-Zuckermann, AZ; Gökler, J; Kaider, A; Riebandt, J; Moayedifar, R; Osorio, E; Haberl, T; Angleitner, P; Laufer, G; Forsythe, J; Knezevic, I; Skoric, B; Erasmus, M; van Cleemput, J; Caliskan, K; De Jonge, N; Szabolcs, Z; Prodán, Z; Wasler, A; Bara, C; Udovičić, M; Sandhaus, T; Garbade, J; Ruhparwar, A; Schoenrath, F; Hirt, S; Antretter, H; Schulz, U; Richter, M; Thul, J; Barten, MJ; Haneya, A; Aleksic, I; Eifert, S; Berchtold-Herz, M; Smits, J; Zuckermann, AO
Donor heart selection and outcomes: An analysis of over 2,000 cases.
J Heart Lung Transplant. 2018; 37(8):976-984
Doi: 10.1016/j.healun.2018.04.014
Web of Science
PubMed
FullText
FullText_MUG
** Gotz, J; Petutschnigg, B; Wasler, A; Wran-Schumer, D; Hansak, P
Bystander resuscitation as a measure of success
NOTFALL RETTUNGSMED. 2017; 20(6): 470-476.
Doi: 10.1007/s10049-016-0256-4
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
** Spiliopoulos, S; Wasler, A; Fruehwald, F; Ablasser, K; Stoschitzky, G; Dapunt, O
Implantation of the HeartMate III Left Ventricular Assist Device in a Giant Left Ventricular Aneurysm: Is Left Ventricular Reconstruction Mandatory?
Circ Heart Fail. 2017; 10(3):e003803-e003803
Doi: 10.1161/CIRCHEARTFAILURE.116.003803
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Dimitriou, AM; Dapunt, O; Knez, I; Wasler, A; Oberwalder, P; Koerfer, R; Tenderich, G; Spiliopoulos, S
Liver failure in total artificial heart therapy.
J Thorac Dis. 2016; 8(7):1546-1549
Doi: 10.21037/jtd.2016.05.81
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Spiliopoulos, S; Wasler, A; Knez, I; Oberwalder, P; Dapunt, O
Systemic Thrombolysis Can Be a Therapy Option Only in Highly Selected Cases of Pump Thrombosis.
ASAIO J. 2016; 62(6):e58-e58
Doi: 10.1097/MAT.0000000000000435
Web of Science
PubMed
FullText
FullText_MUG
** Pichler, P; Antretter, H; Dünser, M; Eschertzhuber, S; Gottardi, R; Heinz, G; Pölzl, G; Pretsch, I; Rajek, A; Wasler, A; Zimpfer, D; Geppert, A
[Use of ECMO in adult patients with cardiogenic shock: a position paper of the Austrian Society of Cardiology].
Wien Klin Wochenschr. 2015; 127(5-6):169-184
Doi: 10.1007/s00508-015-0743-5
Web of Science
PubMed
FullText
FullText_MUG
** Pichler, P; Antretter, H; Dünser, M; Eschertzhuber, S; Gottardi, R; Heinz, G; Pölzl, G; Pretsch, I; Rajek, A; Wasler, A; Zimpfer, D; Geppert, A
Use of ECMO in adult patients with cardiogenic shock: a position paper of the Austrian Society of Cardiology].
Med Klin Intensivmed Notfmed. 2015; 110(6):407-420
Doi: 10.1007/s00063-015-0052-9
Web of Science
PubMed
FullText
FullText_MUG
** Prenner, G; Wasler, A; Fahrleinter-Pammer, A; Werkgartner, G; Mischinger, HJ; Koter, S; Roller, R; Wagner, D
The role of serum albumin in the prediction of malnutrition in patients at least five yr after heart transplantation.
Clin Transplant. 2014; 28(6):737-742
Doi: 10.1111/ctr.12370
Web of Science
PubMed
FullText
FullText_MUG
** Schweiger, M; Klüber, J; Bosch, A; von Levinski, D; Prenner, G; Stiegler, P; Sereinigg, M; Tscheliessnigg, KH; Iberer, F; Wasler, A
Low incidence of coronary angiography in the evaluation process of the potential heart donor.
TRANSPL P. 2014; 46(10): 3339-3342.
Doi: 10.1016/j.transproceed.2014.06.069
Web of Science
PubMed
FullText
FullText_MUG
** Kniepeiss, D; Wagner, D; Wasler, A; Tscheliessnigg, KH; Renner, W
The role of CYP2C8 genotypes in dose requirement and levels of everolimus after heart transplantation.
Wien Klin Wochenschr. 2013; 125(13-14):393-395
Doi: 10.1007/s00508-013-0387-2
Web of Science
PubMed
FullText
FullText_MUG
** Schweiger, M; Schrempf, J; Sereinigg, M; Prenner, G; Tscheliessnigg, KH; Wasler, A; Krumnikel, J; Gamillschegg, A; Knez, I
Complication profile of the Berlin Heart EXCOR biventricular support in children.
Artif Organs. 2013; 37(8):730-735
Doi: 10.1111/aor.12062
Web of Science
PubMed
FullText
FullText_MUG
** Schweiger, M; Stiegler, P; Puntschart, A; Sereinigg, M; Prenner, G; Wasler, A; Tscheliessnigg, K
Everolimus in different combinations as maintenance immunosuppressive therapy in heart transplant recipients.
Exp Clin Transplant. 2012; 10(3):273-277
Doi: 10.6002/ect.2011.0156
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schweiger, M; Vierecke, J; Stiegler, P; Prenner, G; Tscheliessnigg, KH; Wasler, A
Prehospital Care of Left Ventricular Assist Device Patients by Emergency Medical Services.
Prehosp Emerg Care. 2012; 16(4):560-563
Doi: 10.3109/10903127.2012.702192
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Kniepeiss, D; Renner, W; Trummer, O; Wagner, D; Wasler, A; Khoschsorur, GA; Truschnig-Wilders, M; Tscheliessnigg, KH
The role of CYP3A5 genotypes in dose requirements of tacrolimus and everolimus after heart transplantation.
Clin Transplant. 2011; 25(1): 146-150.
Doi: 10.1111/j.1399-0012.2009.01198.x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Schweiger, M; Stiegler, P; Scarpatetti, M; Wasler, A; Sereinigg, M; Prenner, G; Tscheliessnigg, K
Case of Paracoccus yeei infection documented in a transplanted heart.
Transpl Infect Dis. 2011; 13(2): 200-203.
Doi: 10.1111/j.1399-3062.2010.00571.x
Web of Science
PubMed
FullText
FullText_MUG
** Kniepeiss, D; Trummer, O; Wagner, D; Wasler, A; Truschnig-Wilders, M; Iberer, F; Tscheliessnigg, KH; Renner, W
The Role of CYP2C8 Genotypes in Dose Requirement and Levels of Everolimus after Heart Transplantation.
AM J TRANSPLANT. 2011; 11: 683-
[Oral Communication]
Web of Science
** Wagner, D; Dobnig, H; Tscheliessnigg, K; Prenner, G; Wasler, A; Piswagner-Solkner, C; Kniepeiss, D; Fahrleinter, A
TESTOSTERONE REPLACEMENT IN CARDIAC TRANSPLANT PATIENTS ON TOP OF BISPHOSPHONATE THERAPY EXERTS MULTIPLE BENEFITS ON BONE MASS, LIBIDO AND SEXUAL ACTIVITY
TRANSPL INT. 2011; 24: 332-332.
[Oral Communication]
Web of Science
** Wagner, D; Telsnig, B; Kniepeiss, D; Jakoby, E; Schaffellner, S; Fahrleitner-Pammer, A; Wasler, A; Roller, R; Tscheliessnigg, K
THE ROLE OF SERUM ALBUMIN (SA) IN THE PREDICTION OF MALNUTRITION IN PATIENT AT LEAST ONE HEART TRANSPLANTATION (HTX)
TRANSPL INT. 2011; 24: 270-271.
[Poster]
Web of Science
** Hofer, D; Aliabadi, A; Ebner, C; Hormann, C; Mahr, S; Mascherbauer, R; Polzl, G; Reiter, A; Wasler, A; Weber, T; Zink, M; Zuckermann, A; Antretter, H
Evaluation of the potential organ donor with special regards to heart donation
Wien Klin Wochenschr. 2010; 122(13-14):441-451
Doi: 10.1007/s00508-010-1407-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kniepeiss, D; Wagner, D; Wirnsberger, G; Roller, RE; Wasler, A; Iberer, F; Tscheliessnigg, KH
Serum cystatin C is an easy to obtain biomarker for the onset of renal impairment in heart transplant recipients.
J Thorac Cardiovasc Surg. 2010; 140(3):688-693
Doi: 10.1016/j.jtcvs.2010.03.031
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Koestenbauer, S; Stiegler, P; Stadlbauer, V; Mayrhauser, U; Leber, B; Schweiger, M; Wasler, A; Prenner, G; Sereinigg, M; Zelzer, S; Stojakovic, T; Scarpatetti, M; Griesbacher, A; Greilberger, J; Tscheliessnigg, K
Myeloperoxidase and carbonyl proteins: promising markers for non-invasive monitoring of graft rejection after heart transplantation.
J Heart Lung Transplant. 2010; 29(12): 1352-1357.
Doi: 10.1016/j.healun.2010.05.020
Web of Science
PubMed
FullText
FullText_MUG
** von Lewinski, D; Gasser, R; Rainer, PP; Huber, MS; Wilhelm, B; Roessl, U; Haas, T; Wasler, A; Grimm, M; Bisping, E; Pieske, B
Functional effects of glucose transporters in human ventricular myocardium.
Eur J Heart Fail. 2010; 12(2):106-113
Doi: 10.1093/eurjhf/hfp191
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Duller, D; Kniepeiss, D; Wirnsberger, G; Wasler, A; Tscheliessnigg, KH
Serum Cystatin C as an Easy To Obtain Biomarker for the Onset of Late Renal Impairment in Heart Transplantation
J HEART LUNG TRANSPLANT. 2009; 28(2):383--29th Annual Meeting and Scientific Session of the International-Society-for-Heart-and-Lung-Transplantation; APR 22-25, 2009; Paris, FRANCE.
Doi: 10.1016/j.healun.2008.11.390
[Poster]
Web of Science
FullText
FullText_MUG
** Schweiger, M; Stiegler, P; Scarpatetti, M; Wasler, A; Prenner, G; Tscheliessnigg, KH
First documented case of Paracoccus Yeei infection in a transplanted heart.
Transplant International2009; 22(2):138-138.-ESOT, European Society of Organ Transplantation; Aug 28-Sept 2, 2009; Paris, FRANCE.
[Poster]
Web of Science
** Schweiger, M; Stiegler, P; Wasler, A; Prenner, G; Tscheliessnigg, KH
Proteinuria and kidney function after conversion to an Everolimus based immunosuppressive regime after oHTX
Transplant International2009; 22(2):137-137.-ESOT, European Society of Organ Transplantation; Aug 28-Sept 2, 2009; Paris, FRANCE.
[Poster]
Web of Science
** Kahn, J; Müller, H; Marte, W; Rehak, P; Wasler, A; Prenner, G; Tscheliessnigg, K
Establishing extracorporeal membrane oxygenation in a university clinic: case series.
J Cardiothorac Vasc Anesth. 2007; 21(3): 384-387.
Doi: 10.1053/j.jvca.2006.12.022
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Schweiger, M; Wasler, A; Prenner, G; Rauchegger, G; Kniepeiss, D; Tscheliessnigg, KH
Lessons learned with noninvasive cardiac monitoring for acute rejection.
Transplant Proc. 2007; 39(10): 3303-3305.
Doi: 10.1016/j.transproceed.2007.09.005
Web of Science
PubMed
FullText
FullText_MUG
** Kahn, J; Rehak, P; Schweiger, M; Wasler, A; Wascher, T; Tscheliessnigg, KH; Müller, H
The impact of overweight on the development of diabetes after heart transplantation.
Clin Transplant. 2006; 20(1):62-66
Doi: 10.1111/j.1399-0012.2005.00441.x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Schweiger, M; Wasler, A; Prenner, G; Stiegler, P; Stadlbauer, V; Schwarz, M; Tscheliessnigg, K
Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients.
Transpl Immunol. 2006; 16(1): 46-51.
Doi: 10.1016/j.trim.2006.02.001
Web of Science
PubMed
FullText
FullText_MUG
** Gabor, S; Prenner, G; Wasler, A; Schweiger, M; Tscheliessnigg, KH; Smolle-Jüttner, FM
A simplified technique for implantation of left ventricular epicardial leads for biventricular re-synchronization using video-assisted thoracoscopy (VATS).
Eur J Cardiothorac Surg. 2005; 28(6):797-800
Doi: 10.1016/j.ejcts.2005.08.026
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Konstam, MA; Czerska, B; Böhm, M; Oren, RM; Sadowski, J; Khanal, S; Abraham, WT; Wasler, A; Dahm, JB; Gavazzi, A; Gradinac, S; Legrand, V; Mohacsi, P; Poelzl, G; Radovancevic, B; Van Bakel, AB; Zile, MR; Cabuay, B; Bartus, K; Jansen, P
Continuous aortic flow augmentation: a pilot study of hemodynamic and renal responses to a novel percutaneous intervention in decompensated heart failure.
Circulation. 2005; 112(20):3107-3114
Doi: 10.1161/CIRCULATIONAHA.105.555367
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schweiger, M; Wasler, A; Prenner, G; Tripolt, M; Rauchegger, G; Tscheliessnigg, K
The prognostic validity of the ventricular evoked response (VER) signals in cardiac transplantation.
J HEART LUNG TRANSPLANT. 2005; 24(11): 1730-1735.
Doi: 10.1016/j.healun.2005.04.014
Web of Science
PubMed
FullText
FullText_MUG
** Schweiger, M; Wasler, A; Prenner, G; Tripolt, M; Schwarz, M; Tscheliessnigg, KH
Late acute cardiac allograft rejection: new therapeutic options?
Transplant Proc. 2005; 37(10):4528-4531
Doi: 10.1016/j.transproceed.2005.11.053
Web of Science
PubMed
FullText
FullText_MUG
** Schweiger, M; Wasler, A; Prenner, G; Tripolt, M; Zink, M; Duller, D; Schwarz, M; Tscheliessnigg, KH
Improving the rate of organ donation.
TRANSPLANT PROC. 2004; 36(9): 2543-2545.
Doi: 10.1016/j.transproceed.2004.09.068
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Czerska, B; Oren, RM; Bohm, M; Sadowski, J; Van Bakel, AB; Abraham, WT; Wasler, A; Khanal, S; Cabuay, B; Bartus, K; Zile, MR; Konstam, MA
Orqis (R) Cancion (R) Cardiac Recovery System: Hemodynamic effects of a novel minimally-invasive approach to cardio-renal support in severe acute heart failure
J CARD FAIL 2004 10: S22-S23.
Doi: 10.1016/j.cardfail.2004.06.017
Web of Science
FullText
FullText_MUG
** Khanal, S; Czerska, B; Oren, RM; Bohm, M; Sadowski, J; van Bakel, AB; Abraham, WT; Wasler, A; Cabuay, B; Bartus, K; Zile, MR; Konstam, MA
Orqis((R)) Cancion((R)) cardiac recovery system: A novel minimally invasive device to treat acute severe heart failure - Initial safety and efficacy report.
AMER J CARDIOL 2004 94: 198E-199E.
Web of Science
** Knez, I; Doll, N; Wasler, A; Prenner, G; Gabor, S; Michels, K; Tscheliessnigg, KH; Rigler, B
Videothoracoscopic-enhanced biventricular resynchronization: an alternative to failed attempts in endovenous cardiac resynchronization therapy for Chronic heart failure
EUR HEART J 2004 25: 213-213.
Web of Science
** Oren, RM; Czerska, B; Bohm, M; Sadowski, J; Van Bakel, AB; Abraham, WT; Wasler, A; Cabuay, B; Khanal, S; Bartus, K; Zile, MR; Konstam, MA
Cancion (R) Cardiac Recovery System: Effects on renal, echocardiographic, and health status parameters during and following treatment with a novel, minimally invasive approach to cardio-renal support in severe acute heart failure
J CARD FAIL 2004 10: S64-S64.
Doi: 10.1016/j.cardfail.2004.06.169
Web of Science
FullText
FullText_MUG
** Oren, RM; Czerska, B; Bohm, M; Sadowsky, J; Van Bakel, AB; Abraham, WT; Wasler, A; Cabuay, B; Khanal, S; Bartus, K; Zile, MR; Konstam, MA
Cancion((R)) Cardiac Recovery System (CRS): Effects on renal, echocardiographic, and health status parameters during and following treatment with a novel, minimally invasive approach to cardio-renal support in severe acute heart failure
CIRCULATION 2004 110: 605-605.
Web of Science
** Grasser, B; Iberer, F; Schreier, G; Kastner, P; Schaffellner, S; Kniepeiss, D; Kleinert, R; Mahaux, V; Demoulin, JC; Nägele, H; Rödiger, W; Laufer, G; Grimm, M; Zuckermann, A; Wasler, A; Prenner, G; Tscheliessnigg, KH; CHARM Multicenter Investigators Group
Computerized heart allograft-recipient monitoring: a multicenter study.
Transpl Int. 2003; 16(4):225-230
Doi: 10.1007/s00147-002-0530-x
Web of Science
PubMed
FullText
FullText_MUG
** Wasler, A; Radovancevic, B; Fruhwald, F; Tripolt, M; Klein, W; Tscheliessnigg, K
First use of the Cancion cardiac recovery system in a human.
ASAIO J. 2003; 49(1):136-138
Doi: 10.1097%2F00002480-200301000-00023
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Zink, M; Gombotz, H; Wasler, A; Grasser, B; Rehak, P; Metzler, H
Urapidil reduces elevated pulmonary vascular resistance in patients before heart transplantation.
J Heart Lung Transplant. 2002; 21(3):347-353
Doi: 10.1016/S1053-2498(01)00381-3
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Wasler, A; Radovancevic, B; Tripolt, M; Fruhwald, F; Schweiger, M; Klein, W; Tscheliessnigg, KH
First use of the Orqis (TM) Medical Cancion (TM) Cardiac Recovery System (CRS) for heart falure therapy
EUR HEART J 2002 23: 708-708.
Web of Science
** Gilli, R; Macher, S; Posch, U; Rosskopf, K; Schallmoser, K; Sipurzynski, S; Wagner, T; Wasler, A; Tscheliessnigg, K; Lanzer, G
Feasibility of extracorporal photopheresis in patients after heart transplantation
TRANSFUSION 2001 41: 43S-43S.
Web of Science
** Grasser, B; Iberer, F; Schreier, G; Schaffellner, S; Kniepeiss, D; Kastner, P; Kleinert, R; Wasler, A; Grimm, M; Zuckermann, A; Rödiger, W; Naegele, H; Demoulin, H; Mahaux, V; Tscheliessnigg, K
Computerized heart allograft recipient monitoring (CHARM) - a multicenter study.
J Heart Lung Transplant. 2001; 20(2):214-214
PubMed
** Grasser, B; Iberer, F; Schreier, G; Allmayer, A; Schaffellner, S; Prenner, G; Wasler, A; Petutschnigg, B; Müller, H; Tscheliessnigg, K
Intramyocardial electrograms for non-invasive rejection monitoring: initial experience with an infection-specific parameter.
Transpl Int. 1998; 11 Suppl 1(11 Pt 2): S508-S511.
Doi: 10.1111/j.1432-2277.1998.tb01192.x
PubMed
FullText
FullText_MUG
** Grasser, B; Iberer, F; Schreier, G; Schaffellner, S; Kastner, P; Prenner, G; Hipmair, G; Wasler, A; Petutschnigg, B; Muller, H; Hutten, H; Schaldach, M; Tscheliessnigg, K
Pacemaker system configuration for non-invasive rejection monitoring after heart transplantation
HEARTWEB. 1998; 4(1): U33-U37.
Web of Science
** Grasser, B; Iberer, F; Schreier, G; Schaffellner, S; Kastner, P; Prenner, G; Hipmair, G; Wasler, A; Petutschnigg, B; Müller, H; Hutten, H; Schaldach, M; Tscheliessnigg, K
Intramyocardial electrogram variability in the monitoring of graft rejection after heart transplantation.
Pacing Clin Electrophysiol. 1998; 21(11 Pt 2):2345-2349
Doi: 10.1111/j.1540-8159.1998.tb01179.x
Web of Science
PubMed
FullText
FullText_MUG
** Iberer, F; Grasser, B; Schreier, G; Schaffellner, S; Prenner, G; Allmayer, T; Wasler, A; Petutschnigg, B; Müller, H; Kastner, P; Schaldach, M; Hutten, H; Tscheliessnigg, KH
Introducing a new clinical method for noninvasive rejection monitoring after heart transplantation to clinical practice: analysis of paced intramyocardial electrograms.
Transplant Proc. 1998; 30(3):895-899
Doi: 10.1016%2FS0041-1345%2898%2900089-X
Web of Science
PubMed
FullText
FullText_MUG
** Müller, HM; Aigner, R; Horina, JH; Rehak, P; Lang, T; Iberer, F; Wasler, A; Petutschnigg, B; Allmayer, T; Grasser, B; Prenner, G; Schaffellner, S; Tscheliessnigg, KH
Mild chronic anemia following heart transplantation: a syndrome with prognostic relevance?
Transpl Int. 1998; 11(6):413-418
Doi: 10.1007/s001470050167
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Wasler, A; Tscheliessnigg, KH
Mechanical circulatory support in heart failure
Wien Med Wochenschr. 1998; 148(5): 137-142.
PubMed
** Muller, H; Wasler, A; Petutschnigg, B; Allmayer, T; Grasser, B; Prenner, G; Schaffellner, S; Tscheliessnigg, KH
Practical aspects of prostaglandin E-1 before and after solid organ transplantation
ADVAN EXPERIMENT MED BIOL. 1997; 433: 9-12.
Doi: 10.1007/978-1-4899-1810-9_2
Web of Science
PubMed
FullText
FullText_MUG
** Iberer, F; Grasser, B; Schreier, G; Prenner, G; Schaffellner, S; Allmayer, T; Wasler, A; Petutschnigg, B; Müller, H; Hutten, H; Schaldach, M; Tscheliessnigg, KH
Noninvasive rejection monitoring after heart transplant.
TRANSPLANT PROC. 1997; 29(7): 3126-3126.
Doi: 10.1016%2FS0041-1345%2897%2900810-5
Web of Science
PubMed
FullText
FullText_MUG
** Iberer, F; Wasler, A; Petutschnigg, B; Müller, H; Allmayer, T; Grasser, B; Prenner, G; Schaffellner, S; Hipmayr, G; Tscheliessnigg, KH
Prostaglandins in heart transplantation.
Adv Exp Med Biol. 1997; 433(1-2):19-22
Doi: 10.1007/978-1-4899-1810-9_4
Web of Science
PubMed
FullText
FullText_MUG
** Auer, T; Schreier, G; Hutten, H; Kleinert, R; Wasler, A; Petutschnigg, B; Iberer, F; Tscheliessnigg, K; Schaldach, M
Paced epimyocardial electrograms for noninvasive rejection monitoring after heart transplantation
J Heart Lung Transplant. 1996; 15(10):993-998
Web of Science
PubMed
** Auer, T; Schreier, G; Tscheliessnigg, KH; Hutten, H; Allmayr, T; Grasser, B; Wasler, A; Petutschnigg, B; Iberer, F; Schaldach, M
Evoked epimyocardial electrogram for rejection diagnosis after heart transplantation.
Transpl Int. 1996; 9 Suppl 1(3):S243-S246
Doi: 10.1007/978-3-662-00818-8_63
PubMed
FullText
FullText_MUG
** Auer, T; Weihs, W; Grasser, B; Schmidt, B; Petutschnigg, B; Wasler, A; Iberer, F; Tscheliessnigg, KH
Donor heart quality control. Analysis of echocardiographic (EC) findings and patient outcome.
Transpl Int. 1996; 9 Suppl 1(3):S409-S413
Doi: 10.1007/978-3-662-00818-8_98
PubMed
FullText
FullText_MUG
** Egger, G; Allmayer, T; Iberer, F; Tscheliessnigg, KH; Auer, T; Wasler, A; Petutschnigg, B
Impaired Polymorphonuclear Leukocyte Migration as a Possible Monitor for the Risk of Septicemia in Immunosuppressed Transplant Patients
MED SCI RES 1996 24: 17-19.
Web of Science
** Grasser, B; Schreier, G; Iberer, F; Wasler, A; Petutschnigg, B; Müller, H; Prenner, G; Hipmair, G; Hutten, H; Schaldach, M; Tscheliessnigg, KH
Noninvasive monitoring of rejection therapy based on intramyocardial electrograms after orthotopic heart transplantation.
Transplant Proc. 1996; 28(6):3276-3277
Web of Science
PubMed
** Iberer, F; Tscheliessnigg, K; Halwachs, G; Rehak, P; Wasler, A; Petutschnigg, B; Schreier, G; Müller, H; Allmayer, T; Freigassner, M; Prenner, G; Hipmair, G; Grasser, B
Definitions of cytomegalovirus disease after heart transplantation: antigenemia as a marker for antiviral therapy.
Transpl Int. 1996; 9(3):236-242
Doi: 10.1007/BF00335392
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Iberer, F; Tscheliessnigg, K; Halwachs, G; Auer, T; Wasler, A; Petutschnigg, B; Schreier, G; Müller, H; Allmayr, T; Prenner, G; Hipmair, G; Grasser, B; Freigassner, M
Cytomegalovirus antigenemia as a marker for antiviral therapy after heart transplantation.
J Heart Lung Transplant. 1996; 15(3):314-315
Web of Science
PubMed
** Auer, T; Khoschsorur, GA; Rabl, H; Iberer, F; Petutschnigg, B; Wasler, A; Tscheliessnigg, KH
Detection of lipid peroxidation products by malondialdehyde (MDA-TBA reaction) in organ transplantation.
Transplant Proc. 1995; 27(5):2749-2751
Web of Science
PubMed
** Auer, T; Schreier, G; Hutten, H; Schaldach, M; Iberer, F; Petutschnigg, B; Wasler, A; Müller, H; Allmeyer, T; Tscheliessnigg, KH
Intramyocardial electrograms for monitoring of allograft rejection after heart transplantation.
Transplant Proc. 1995; 27(3):1983-1985
Web of Science
PubMed
** Auer, T; Schreier, G; Hutten, H; Tscheliessnigg, KH; Allmayr, T; Grasser, B; Iberer, F; Wasler, A; Petutschnigg, B; Müller, H
Intramyocardial electrograms for the monitoring of allograft rejection after heart transplantation using spontaneous and paced beats.
Transplant Proc. 1995; 27(5):2621-2624
Web of Science
PubMed
** Iberer, F; Tscheliessnigg, K; Halwachs, G; Auer, T; Wasler, A; Petutschnigg, B; Schreier, G; Müller, H; Allmayer, T; Prenner, G
Cytomegalovirus after heart transplantation: definitions for the guidance of antiviral therapy.
Scand J Infect Dis Suppl. 1995; 99(3):100-103
Web of Science
PubMed
** Iberer, F; Tscheliessnigg, KH; Halwachs, G; Auer, T; Wasler, A; Petutschnigg, B; Müller, H; Freigassner, M; Allmayr, T; Hipmair, G
CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
Wien Klin Wochenschr. 1995; 107(23):718-722
Web of Science
PubMed
** Wasler, A; Iberer, F; Auer, T; Petutschnigg, B; Müller, H; Pfeifer, J; Deutsch, T; Tscheliessnigg, KH
Treatment of leukopenia with granulocyte-macrophage colony-stimulating factor after heart transplantation.
Transplant Proc. 1995; 27(5):2633-2634
Web of Science
PubMed
** Iberer, F; Halwachs-Baumann, G; Rödl, S; Pleisnitzer, A; Wasler, A; Auer, T; Petutschnigg, B; Müller, H; Tscheliessnigg, K; Wilders-Truschnig, M
Monitoring of cytomegalovirus disease after heart transplantation: persistence of anti-cytomegalovirus IgM antibodies.
J Heart Lung Transplant. 1994; 13(3):405-411
Web of Science
PubMed
Google Scholar
** Iberer, F; Tscheliessnigg, KH; Freigassner, M; Auer, T; Kleinert, R; Wasler, A; Petutschnigg, B; Müller, H
Clinical experience with a monoclonal interleukin-2 receptor antibody (BT 563) for rejection therapy after orthotopic heart transplantation.
Transplant Proc. 1994; 26(6):3237-3239
Web of Science
PubMed
** Iberer, F; Vujicic, R; Rödl, S; Wasler, A; Sabin, K; Koshsorur, A; Allmayer, T; Auer, T; Petutschnigg, B; Tscheliessnigg, KH
Effects of prostaglandin E1 therapy on cyclosporine A and creatinine levels after orthotopic heart transplantation.
Transplant Proc. 1994; 26(6):3246-3248
Web of Science
PubMed
** Halwachs, G; Zach, R; Pogglitsch, H; Holzer, H; Tiran, A; Iberer, F; Wasler, A; Tscheliessnigg, HP; Lanzer, G; Fölsch, B
A rapid immunocytochemical assay for CMV detection in peripheral blood of organ-transplanted patients in clinical practice.
Transplantation. 1993; 56(2):338-342
Doi: 10.1097/00007890-199308000-00016
Web of Science
PubMed
FullText
FullText_MUG
** Iberer, F; Wasler, A; Tscheliessnigg, K; Petutschnigg, B; Auer, T; Müller, H; Rödl, S
Prostaglandin E1-induced moderation of elevated pulmonary vascular resistance. Survival on waiting list and results of orthotopic heart transplantation.
J Heart Lung Transplant. 1993; 12(2):173-178
Web of Science
PubMed
** Iberer, F; Königsrainer, A; Wasler, A; Petutschnigg, B; Auer, T; Tscheliessnigg, K
Cardiac allograft harvesting after carbon monoxide poisoning. Report of a successful orthotopic heart transplantation.
J Heart Lung Transplant. 1993; 12(3):499-500
(- Case Report)
Web of Science
PubMed
** Wasler, A; Iberer, F; Tscheliessnigg, KH; Auer, T; Petutschnigg, B
Prostaglandin E1 in the pretransplantation period in patients with pulmonary hypertension.
J Heart Lung Transplant. 1993; 12(5):884-884
Web of Science
PubMed
** Iberer, F; Wasler, A; Tscheliessnigg, K; Vujicic, R; Rehak, P; Giegerl, E; Popper, HH; Kleinert, R; Berger, J; Auer, T
Prostaglandin E1 reduces the frequency of rejection after heart transplantation.
J Heart Lung Transplant. 1992; 11(4 Pt 1):727-732
Web of Science
PubMed
Google Scholar
** Wasler, A; Iberer, F; Tscheliessnigg, KH; Metzler, H; Gombotz, H; Berger, J; Auer, T; Petutschnigg, B
Preoperative prostaglandin E1 treatment to prevent right ventricular failure after orthotopic heart transplantation.
Transpl Int. 1992; 5 Suppl 1(4 Pt 1):S224-S227
Doi: 10.1007/978-3-642-77423-2_72
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Wasler, A; Petutschnigg, B; Iberer, F; Auer, T; Tscheliessnigg, KH
[Noninvasive monitoring of rejection in heart transplant patients. An overview of current status and use at a small transplant center].
Wien Klin Wochenschr. 1991; 103(4):105-110
Web of Science
PubMed